APO Research

APO RESEARCH · REPORT

Oral Finasteride Tablet

Selected research

Industry Growth & Trends

Global Oral Finasteride Tablet Industry Growth and Trends Forecast to 2032

Market perspective

The global Oral Finasteride Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Finasteride Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Finasteride Tablet include Zhejiang Xianju Pharmaceutical Co., Ltd, Tianfang Pharmaceutical Co., Ltd, Shanghai Xinya Pharmaceutical Minhang Co., Ltd, Shanghai Hyundai Pharmaceutical Co., Ltd, Sandoz, Renhetang Pharmaceutical Company Limited, Nanjing Shenghe Pharmaceutical Co., Ltd, Nanjing Sea Whale Pharmaceutical Co., Ltd and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Finasteride Tablet market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Finasteride Tablet market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Finasteride Tablet market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Finasteride Tablet.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Finasteride Tablet market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Finasteride Tablet Market by Company

Zhejiang Xianju Pharmaceutical Co., Ltd

Tianfang Pharmaceutical Co., Ltd

Shanghai Xinya Pharmaceutical Minhang Co., Ltd

Shanghai Hyundai Pharmaceutical Co., Ltd

Sandoz

Renhetang Pharmaceutical Company Limited

Nanjing Shenghe Pharmaceutical Co., Ltd

Nanjing Sea Whale Pharmaceutical Co., Ltd

Merck

Runenberg Pharmaceuticals Ltd

CR SECCO Pharmaceutical Co., Ltd

Hunan Zhengqing Pharmaceutical Group Co., Ltd

Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd

Hunan Baicao Pharmaceutical Co., Ltd

Hangzhou Kangenbei Pharmaceutical Co., Ltd

Guangdong Yishu Pharmaceutical Co., Ltd

RelonChem

Dr. Reddy

Cipla

Actavis

Accord Pharmaceuticals

Oral Finasteride Tablet Segment by Type

1mg

5mg

Oral Finasteride Tablet Segment by Application

Urology

Dermatology

Oral Finasteride Tablet Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Finasteride Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Finasteride Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Finasteride Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Finasteride Tablet manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Finasteride Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg Table 2. Major Company of 5mg Table 3. Global Oral Finasteride Tablet Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 5. Global Oral Finasteride Tablet Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral Finasteride Tablet Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral Finasteride Tablet Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral Finasteride Tablet Price by Type (2021-2026) & (US$/Unit) Table 9. Global Oral Finasteride Tablet Sales by Type (2027-2032) & (K Units) Table 10. Global Oral Finasteride Tablet Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral Finasteride Tablet Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral Finasteride Tablet Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral Finasteride Tablet Price by Type (2027-2032) & (US$/Unit) Table 14. North America Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 15. North America Oral Finasteride Tablet Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 17. Europe Oral Finasteride Tablet Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Oral Finasteride Tablet Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 21. Latin America Oral Finasteride Tablet Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral Finasteride Tablet Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Oral Finasteride Tablet Sales by Type (2021-2026) & (US$ Million) Table 24. Oral Finasteride Tablet Industry Trends Table 25. Oral Finasteride Tablet Industry Drivers Table 26. Oral Finasteride Tablet Industry Opportunities and Challenges Table 27. Oral Finasteride Tablet Industry Restraints Table 28. Global Oral Finasteride Tablet Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral Finasteride Tablet Revenue Market Share by Company (2021-2026) Table 30. Global Oral Finasteride Tablet Sales by Company (2021-2026) & (K Units) Table 31. Global Oral Finasteride Tablet Sales Share by Company (2021-2026) Table 32. Global Oral Finasteride Tablet Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Oral Finasteride Tablet Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral Finasteride Tablet Major Company Production Sites and Headquarters Table 35. Global Oral Finasteride Tablet Company, Product Type & Application Table 36. Global Oral Finasteride Tablet Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral Finasteride Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral Finasteride Tablet Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral Finasteride Tablet Sales by Region (2021-2026) & (K Units) Table 41. Global Oral Finasteride Tablet Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral Finasteride Tablet Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral Finasteride Tablet Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Oral Finasteride Tablet Sales by Region (2027-2032) & (K Units) Table 46. Global Oral Finasteride Tablet Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral Finasteride Tablet Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral Finasteride Tablet Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral Finasteride Tablet Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Oral Finasteride Tablet Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 52. Global Oral Finasteride Tablet Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral Finasteride Tablet Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral Finasteride Tablet Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral Finasteride Tablet Price by Application (2021-2026) & (US$/Unit) Table 56. Global Oral Finasteride Tablet Sales by Application (2027-2032) & (K Units) Table 57. Global Oral Finasteride Tablet Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral Finasteride Tablet Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral Finasteride Tablet Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral Finasteride Tablet Price by Application (2027-2032) & (US$/Unit) Table 61. North America Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 62. North America Oral Finasteride Tablet Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 64. Europe Oral Finasteride Tablet Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Oral Finasteride Tablet Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 68. Latin America Oral Finasteride Tablet Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral Finasteride Tablet Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Oral Finasteride Tablet Sales by Application (2021-2026) & (US$ Million) Table 71. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information Table 72. Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview Table 73. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 75. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development Table 76. Tianfang Pharmaceutical Co., Ltd Company Information Table 77. Tianfang Pharmaceutical Co., Ltd Business Overview Table 78. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 80. Tianfang Pharmaceutical Co., Ltd Recent Development Table 81. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information Table 82. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview Table 83. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio Table 85. Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Development Table 86. Shanghai Hyundai Pharmaceutical Co., Ltd Company Information Table 87. Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview Table 88. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 90. Shanghai Hyundai Pharmaceutical Co., Ltd Recent Development Table 91. Sandoz Company Information Table 92. Sandoz Business Overview Table 93. Sandoz Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Sandoz Oral Finasteride Tablet Product Portfolio Table 95. Sandoz Recent Development Table 96. Renhetang Pharmaceutical Company Limited Company Information Table 97. Renhetang Pharmaceutical Company Limited Business Overview Table 98. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio Table 100. Renhetang Pharmaceutical Company Limited Recent Development Table 101. Nanjing Shenghe Pharmaceutical Co., Ltd Company Information Table 102. Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview Table 103. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 105. Nanjing Shenghe Pharmaceutical Co., Ltd Recent Development Table 106. Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information Table 107. Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview Table 108. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 110. Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Development Table 111. Merck Company Information Table 112. Merck Business Overview Table 113. Merck Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Merck Oral Finasteride Tablet Product Portfolio Table 115. Merck Recent Development Table 116. Runenberg Pharmaceuticals Ltd Company Information Table 117. Runenberg Pharmaceuticals Ltd Business Overview Table 118. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio Table 120. Runenberg Pharmaceuticals Ltd Recent Development Table 121. CR SECCO Pharmaceutical Co., Ltd Company Information Table 122. CR SECCO Pharmaceutical Co., Ltd Business Overview Table 123. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 125. CR SECCO Pharmaceutical Co., Ltd Recent Development Table 126. Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information Table 127. Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview Table 128. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio Table 130. Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Development Table 131. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information Table 132. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview Table 133. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 134. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 135. Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Development Table 136. Hunan Baicao Pharmaceutical Co., Ltd Company Information Table 137. Hunan Baicao Pharmaceutical Co., Ltd Business Overview Table 138. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 139. Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 140. Hunan Baicao Pharmaceutical Co., Ltd Recent Development Table 141. Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information Table 142. Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview Table 143. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 144. Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 145. Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Development Table 146. Guangdong Yishu Pharmaceutical Co., Ltd Company Information Table 147. Guangdong Yishu Pharmaceutical Co., Ltd Business Overview Table 148. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 149. Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio Table 150. Guangdong Yishu Pharmaceutical Co., Ltd Recent Development Table 151. RelonChem Company Information Table 152. RelonChem Business Overview Table 153. RelonChem Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 154. RelonChem Oral Finasteride Tablet Product Portfolio Table 155. RelonChem Recent Development Table 156. Dr. Reddy Company Information Table 157. Dr. Reddy Business Overview Table 158. Dr. Reddy Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 159. Dr. Reddy Oral Finasteride Tablet Product Portfolio Table 160. Dr. Reddy Recent Development Table 161. Cipla Company Information Table 162. Cipla Business Overview Table 163. Cipla Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 164. Cipla Oral Finasteride Tablet Product Portfolio Table 165. Cipla Recent Development Table 166. Actavis Company Information Table 167. Actavis Business Overview Table 168. Actavis Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 169. Actavis Oral Finasteride Tablet Product Portfolio Table 170. Actavis Recent Development Table 171. Accord Pharmaceuticals Company Information Table 172. Accord Pharmaceuticals Business Overview Table 173. Accord Pharmaceuticals Oral Finasteride Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 174. Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio Table 175. Accord Pharmaceuticals Recent Development Table 176. North America Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 177. North America Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 178. North America Oral Finasteride Tablet Sales Market Share by Country (2021-2026) Table 179. North America Oral Finasteride Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 180. North America Oral Finasteride Tablet Sales Market Share Forecast by Country (2027-2032) Table 181. North America Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. North America Oral Finasteride Tablet Market Size by Country (2021-2026) & (US$ Million) Table 183. North America Oral Finasteride Tablet Market Share by Country (2021-2026) Table 184. North America Oral Finasteride Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. North America Oral Finasteride Tablet Market Share Forecast by Country (2027-2032) Table 186. Europe Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 187. Europe Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 188. Europe Oral Finasteride Tablet Sales Market Share by Country (2021-2026) Table 189. Europe Oral Finasteride Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 190. Europe Oral Finasteride Tablet Sales Market Share Forecast by Country (2027-2032) Table 191. Europe Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Europe Oral Finasteride Tablet Market Size by Country (2021-2026) & (US$ Million) Table 193. Europe Oral Finasteride Tablet Market Share by Country (2021-2026) Table 194. Europe Oral Finasteride Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Europe Oral Finasteride Tablet Market Share Forecast by Country (2027-2032) Table 196. Asia-Pacific Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 197. Asia-Pacific Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 198. Asia-Pacific Oral Finasteride Tablet Sales Market Share by Country (2021-2026) Table 199. Asia-Pacific Oral Finasteride Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 200. Asia-Pacific Oral Finasteride Tablet Sales Market Share Forecast by Country (2027-2032) Table 201. Asia-Pacific Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Asia-Pacific Oral Finasteride Tablet Market Size by Country (2021-2026) & (US$ Million) Table 203. Asia-Pacific Oral Finasteride Tablet Market Share by Country (2021-2026) Table 204. Asia-Pacific Oral Finasteride Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Asia-Pacific Oral Finasteride Tablet Market Share Forecast by Country (2027-2032) Table 206. Latin America Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 207. Latin America Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 208. Latin America Oral Finasteride Tablet Sales Market Share by Country (2021-2026) Table 209. Latin America Oral Finasteride Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 210. Latin America Oral Finasteride Tablet Sales Market Share Forecast by Country (2027-2032) Table 211. Latin America Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 212. Latin America Oral Finasteride Tablet Market Size by Country (2021-2026) & (US$ Million) Table 213. Latin America Oral Finasteride Tablet Market Share by Country (2021-2026) Table 214. Latin America Oral Finasteride Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 215. Latin America Oral Finasteride Tablet Market Share Forecast by Country (2027-2032) Table 216. Middle East and Africa Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 217. Middle East and Africa Oral Finasteride Tablet Sales by Country (2021-2026) & (K Units) Table 218. Middle East and Africa Oral Finasteride Tablet Sales Market Share by Country (2021-2026) Table 219. Middle East and Africa Oral Finasteride Tablet Sales Forecast by Country (2027-2032) & (K Units) Table 220. Middle East and Africa Oral Finasteride Tablet Sales Market Share Forecast by Country (2027-2032) Table 221. Middle East and Africa Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 222. Middle East and Africa Oral Finasteride Tablet Market Size by Country (2021-2026) & (US$ Million) Table 223. Middle East and Africa Oral Finasteride Tablet Market Share by Country (2021-2026) Table 224. Middle East and Africa Oral Finasteride Tablet Market Size Forecast by Country (2027-2032) & (US$ Million) Table 225. Middle East and Africa Oral Finasteride Tablet Market Share Forecast by Country (2027-2032) Table 226. Key Raw Materials Table 227. Raw Materials Key Suppliers Table 228. Oral Finasteride Tablet Distributors List Table 229. Oral Finasteride Tablet Customers List Table 230. Research Programs/Design for This Report Table 231. Authors List of This Report Table 232. Secondary Sources Table 233. Primary Sources List of Figures Figure 1. Oral Finasteride Tablet Image Figure 2. Global Oral Finasteride Tablet Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Finasteride Tablet Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Finasteride Tablet Sales (2021-2032) & (K Units) Figure 5. 1mg Image Figure 6. Global 1mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 5mg Image Figure 8. Global 5mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Oral Finasteride Tablet Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral Finasteride Tablet Market Share by Type 2025 VS 2032 Figure 11. North America Oral Finasteride Tablet Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral Finasteride Tablet Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral Finasteride Tablet Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral Finasteride Tablet Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral Finasteride Tablet Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral Finasteride Tablet Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral Finasteride Tablet Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral Finasteride Tablet Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral Finasteride Tablet Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral Finasteride Tablet Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral Finasteride Tablet Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Urology Image Figure 24. Global Urology Sales YoY Growth (2021-2032) & (K Units) Figure 25. Dermatology Image Figure 26. Global Dermatology Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Oral Finasteride Tablet Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Oral Finasteride Tablet Market Share by Application 2025 VS 2032 Figure 29. North America Oral Finasteride Tablet Sales Market Share in Volume by Application in 2025 Figure 30. North America Oral Finasteride Tablet Sales Market Share in Value by Application in 2025 Figure 31. Europe Oral Finasteride Tablet Sales Market Share in Volume by Application in 2025 Figure 32. Europe Oral Finasteride Tablet Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Oral Finasteride Tablet Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Oral Finasteride Tablet Sales Market Share in Value by Application in 2025 Figure 35. Latin America Oral Finasteride Tablet Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Oral Finasteride Tablet Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Oral Finasteride Tablet Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Oral Finasteride Tablet Sales Market Share in Value by Application in 2025 Figure 39. North America Oral Finasteride Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Oral Finasteride Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Oral Finasteride Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Oral Finasteride Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Oral Finasteride Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Oral Finasteride Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oral Finasteride Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Oral Finasteride Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Oral Finasteride Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Oral Finasteride Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oral Finasteride Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Oral Finasteride Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Oral Finasteride Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Oral Finasteride Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oral Finasteride Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Oral Finasteride Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Oral Finasteride Tablet Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Oral Finasteride Tablet Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oral Finasteride Tablet Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Oral Finasteride Tablet Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Oral Finasteride Tablet Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Oral Finasteride Tablet Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 5mg
Applications
  • Urology
  • Dermatology
Companies covered
  • Zhejiang Xianju Pharmaceutical Co., Ltd
  • Tianfang Pharmaceutical Co., Ltd
  • Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  • Shanghai Hyundai Pharmaceutical Co., Ltd
  • Sandoz
  • Renhetang Pharmaceutical Company Limited
  • Nanjing Shenghe Pharmaceutical Co., Ltd
  • Nanjing Sea Whale Pharmaceutical Co., Ltd
  • Merck
  • Runenberg Pharmaceuticals Ltd
  • CR SECCO Pharmaceutical Co., Ltd
  • Hunan Zhengqing Pharmaceutical Group Co., Ltd
  • Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  • Hunan Baicao Pharmaceutical Co., Ltd
  • Hangzhou Kangenbei Pharmaceutical Co., Ltd
  • Guangdong Yishu Pharmaceutical Co., Ltd
  • RelonChem
  • Dr. Reddy
  • Cipla
  • Actavis
  • Accord Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Finasteride Tablet Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Finasteride Tablet Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Finasteride Tablet Market by Type
  6. 1.3.1 1mg
  7. 1.3.2 5mg
  8. 1.4 Global Oral Finasteride Tablet Market Size by Type
  9. 1.4.1 Global Oral Finasteride Tablet Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral Finasteride Tablet Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral Finasteride Tablet Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral Finasteride Tablet Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral Finasteride Tablet Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral Finasteride Tablet Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral Finasteride Tablet Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral Finasteride Tablet Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Finasteride Tablet Industry Trends
  2. 2.2 Oral Finasteride Tablet Industry Drivers
  3. 2.3 Oral Finasteride Tablet Industry Opportunities and Challenges
  4. 2.4 Oral Finasteride Tablet Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Finasteride Tablet Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Finasteride Tablet Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Finasteride Tablet Price (2021-2026)
  4. 3.4 Global Oral Finasteride Tablet Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Finasteride Tablet Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Finasteride Tablet Company, Product Type & Application
  7. 3.7 Global Oral Finasteride Tablet Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Finasteride Tablet Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Finasteride Tablet Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Finasteride Tablet Tier 1, Tier 2, and Tier 3
4 Oral Finasteride Tablet Regional Status and Outlook
  1. 4.1 Global Oral Finasteride Tablet Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Finasteride Tablet Historic Market Size by Region
  3. 4.2.1 Global Oral Finasteride Tablet Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Finasteride Tablet Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Finasteride Tablet Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Finasteride Tablet Forecasted Market Size by Region
  7. 4.3.1 Global Oral Finasteride Tablet Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Finasteride Tablet Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Finasteride Tablet Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Finasteride Tablet by Application
  1. 5.1 Oral Finasteride Tablet Market by Application
  2. 5.1.1 Urology
  3. 5.1.2 Dermatology
  4. 5.2 Global Oral Finasteride Tablet Market Size by Application
  5. 5.2.1 Global Oral Finasteride Tablet Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oral Finasteride Tablet Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oral Finasteride Tablet Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oral Finasteride Tablet Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oral Finasteride Tablet Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oral Finasteride Tablet Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oral Finasteride Tablet Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oral Finasteride Tablet Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Xianju Pharmaceutical Co., Ltd
  2. 6.1.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
  3. 6.1.2 Zhejiang Xianju Pharmaceutical Co., Ltd Business Overview
  4. 6.1.3 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Xianju Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  6. 6.1.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Developments
  7. 6.2 Tianfang Pharmaceutical Co., Ltd
  8. 6.2.1 Tianfang Pharmaceutical Co., Ltd Company Information
  9. 6.2.2 Tianfang Pharmaceutical Co., Ltd Business Overview
  10. 6.2.3 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Tianfang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  12. 6.2.5 Tianfang Pharmaceutical Co., Ltd Recent Developments
  13. 6.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd
  14. 6.3.1 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Company Information
  15. 6.3.2 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Business Overview
  16. 6.3.3 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Oral Finasteride Tablet Product Portfolio
  18. 6.3.5 Shanghai Xinya Pharmaceutical Minhang Co., Ltd Recent Developments
  19. 6.4 Shanghai Hyundai Pharmaceutical Co., Ltd
  20. 6.4.1 Shanghai Hyundai Pharmaceutical Co., Ltd Company Information
  21. 6.4.2 Shanghai Hyundai Pharmaceutical Co., Ltd Business Overview
  22. 6.4.3 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Shanghai Hyundai Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  24. 6.4.5 Shanghai Hyundai Pharmaceutical Co., Ltd Recent Developments
  25. 6.5 Sandoz
  26. 6.5.1 Sandoz Company Information
  27. 6.5.2 Sandoz Business Overview
  28. 6.5.3 Sandoz Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sandoz Oral Finasteride Tablet Product Portfolio
  30. 6.5.5 Sandoz Recent Developments
  31. 6.6 Renhetang Pharmaceutical Company Limited
  32. 6.6.1 Renhetang Pharmaceutical Company Limited Company Information
  33. 6.6.2 Renhetang Pharmaceutical Company Limited Business Overview
  34. 6.6.3 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Renhetang Pharmaceutical Company Limited Oral Finasteride Tablet Product Portfolio
  36. 6.6.5 Renhetang Pharmaceutical Company Limited Recent Developments
  37. 6.7 Nanjing Shenghe Pharmaceutical Co., Ltd
  38. 6.7.1 Nanjing Shenghe Pharmaceutical Co., Ltd Company Information
  39. 6.7.2 Nanjing Shenghe Pharmaceutical Co., Ltd Business Overview
  40. 6.7.3 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Nanjing Shenghe Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  42. 6.7.5 Nanjing Shenghe Pharmaceutical Co., Ltd Recent Developments
  43. 6.8 Nanjing Sea Whale Pharmaceutical Co., Ltd
  44. 6.8.1 Nanjing Sea Whale Pharmaceutical Co., Ltd Company Information
  45. 6.8.2 Nanjing Sea Whale Pharmaceutical Co., Ltd Business Overview
  46. 6.8.3 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Nanjing Sea Whale Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  48. 6.8.5 Nanjing Sea Whale Pharmaceutical Co., Ltd Recent Developments
  49. 6.9 Merck
  50. 6.9.1 Merck Company Information
  51. 6.9.2 Merck Business Overview
  52. 6.9.3 Merck Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck Oral Finasteride Tablet Product Portfolio
  54. 6.9.5 Merck Recent Developments
  55. 6.10 Runenberg Pharmaceuticals Ltd
  56. 6.10.1 Runenberg Pharmaceuticals Ltd Company Information
  57. 6.10.2 Runenberg Pharmaceuticals Ltd Business Overview
  58. 6.10.3 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Runenberg Pharmaceuticals Ltd Oral Finasteride Tablet Product Portfolio
  60. 6.10.5 Runenberg Pharmaceuticals Ltd Recent Developments
  61. 6.11 CR SECCO Pharmaceutical Co., Ltd
  62. 6.11.1 CR SECCO Pharmaceutical Co., Ltd Company Information
  63. 6.11.2 CR SECCO Pharmaceutical Co., Ltd Business Overview
  64. 6.11.3 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CR SECCO Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  66. 6.11.5 CR SECCO Pharmaceutical Co., Ltd Recent Developments
  67. 6.12 Hunan Zhengqing Pharmaceutical Group Co., Ltd
  68. 6.12.1 Hunan Zhengqing Pharmaceutical Group Co., Ltd Company Information
  69. 6.12.2 Hunan Zhengqing Pharmaceutical Group Co., Ltd Business Overview
  70. 6.12.3 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Hunan Zhengqing Pharmaceutical Group Co., Ltd Oral Finasteride Tablet Product Portfolio
  72. 6.12.5 Hunan Zhengqing Pharmaceutical Group Co., Ltd Recent Developments
  73. 6.13 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd
  74. 6.13.1 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Company Information
  75. 6.13.2 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Business Overview
  76. 6.13.3 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  78. 6.13.5 Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd Recent Developments
  79. 6.14 Hunan Baicao Pharmaceutical Co., Ltd
  80. 6.14.1 Hunan Baicao Pharmaceutical Co., Ltd Company Information
  81. 6.14.2 Hunan Baicao Pharmaceutical Co., Ltd Business Overview
  82. 6.14.3 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Hunan Baicao Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  84. 6.14.5 Hunan Baicao Pharmaceutical Co., Ltd Recent Developments
  85. 6.15 Hangzhou Kangenbei Pharmaceutical Co., Ltd
  86. 6.15.1 Hangzhou Kangenbei Pharmaceutical Co., Ltd Company Information
  87. 6.15.2 Hangzhou Kangenbei Pharmaceutical Co., Ltd Business Overview
  88. 6.15.3 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Hangzhou Kangenbei Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  90. 6.15.5 Hangzhou Kangenbei Pharmaceutical Co., Ltd Recent Developments
  91. 6.16 Guangdong Yishu Pharmaceutical Co., Ltd
  92. 6.16.1 Guangdong Yishu Pharmaceutical Co., Ltd Company Information
  93. 6.16.2 Guangdong Yishu Pharmaceutical Co., Ltd Business Overview
  94. 6.16.3 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Guangdong Yishu Pharmaceutical Co., Ltd Oral Finasteride Tablet Product Portfolio
  96. 6.16.5 Guangdong Yishu Pharmaceutical Co., Ltd Recent Developments
  97. 6.17 RelonChem
  98. 6.17.1 RelonChem Company Information
  99. 6.17.2 RelonChem Business Overview
  100. 6.17.3 RelonChem Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 RelonChem Oral Finasteride Tablet Product Portfolio
  102. 6.17.5 RelonChem Recent Developments
  103. 6.18 Dr. Reddy
  104. 6.18.1 Dr. Reddy Company Information
  105. 6.18.2 Dr. Reddy Business Overview
  106. 6.18.3 Dr. Reddy Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 Dr. Reddy Oral Finasteride Tablet Product Portfolio
  108. 6.18.5 Dr. Reddy Recent Developments
  109. 6.19 Cipla
  110. 6.19.1 Cipla Company Information
  111. 6.19.2 Cipla Business Overview
  112. 6.19.3 Cipla Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 Cipla Oral Finasteride Tablet Product Portfolio
  114. 6.19.5 Cipla Recent Developments
  115. 6.20 Actavis
  116. 6.20.1 Actavis Company Information
  117. 6.20.2 Actavis Business Overview
  118. 6.20.3 Actavis Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Actavis Oral Finasteride Tablet Product Portfolio
  120. 6.20.5 Actavis Recent Developments
  121. 6.21 Accord Pharmaceuticals
  122. 6.21.1 Accord Pharmaceuticals Company Information
  123. 6.21.2 Accord Pharmaceuticals Business Overview
  124. 6.21.3 Accord Pharmaceuticals Oral Finasteride Tablet Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 Accord Pharmaceuticals Oral Finasteride Tablet Product Portfolio
  126. 6.21.5 Accord Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Oral Finasteride Tablet Sales by Country
  2. 7.1.1 North America Oral Finasteride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Finasteride Tablet Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Finasteride Tablet Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Finasteride Tablet Market Size by Country
  6. 7.2.1 North America Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Finasteride Tablet Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Finasteride Tablet Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Finasteride Tablet Sales by Country
  2. 8.1.1 Europe Oral Finasteride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Finasteride Tablet Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Finasteride Tablet Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Finasteride Tablet Market Size by Country
  6. 8.2.1 Europe Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Finasteride Tablet Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Finasteride Tablet Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Finasteride Tablet Sales by Country
  2. 9.1.1 Asia-Pacific Oral Finasteride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Finasteride Tablet Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Finasteride Tablet Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Finasteride Tablet Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Finasteride Tablet Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Finasteride Tablet Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Finasteride Tablet Sales by Country
  2. 10.1.1 South America Oral Finasteride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Finasteride Tablet Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Finasteride Tablet Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Finasteride Tablet Market Size by Country
  6. 10.2.1 South America Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Finasteride Tablet Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Finasteride Tablet Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Finasteride Tablet Sales by Country
  2. 11.1.1 Middle East and Africa Oral Finasteride Tablet Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Finasteride Tablet Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Finasteride Tablet Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Finasteride Tablet Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Finasteride Tablet Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Finasteride Tablet Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Finasteride Tablet Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Finasteride Tablet Value Chain Analysis
  2. 12.1.1 Oral Finasteride Tablet Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Finasteride Tablet Production Mode & Process
  7. 12.2 Oral Finasteride Tablet Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Finasteride Tablet Distributors
  10. 12.2.3 Oral Finasteride Tablet Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research